Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,233 | 400 | 97.8% |
| Education | $156.99 | 2 | 1.9% |
| Gift | $27.28 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,844 | 83 | $0 (2024) |
| Janssen Biotech, Inc. | $1,007 | 59 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $891.10 | 48 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $559.00 | 33 | $0 (2024) |
| GENZYME CORPORATION | $425.70 | 20 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $372.19 | 28 | $0 (2024) |
| PFIZER INC. | $304.73 | 7 | $0 (2024) |
| Olympus America Inc. | $262.52 | 2 | $0 (2023) |
| Celgene Corporation | $249.65 | 16 | $0 (2023) |
| NESTLE HEALTHCARE NUTRITION INC. | $239.01 | 12 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,002 | 96 | ABBVIE INC. ($550.20) |
| 2023 | $1,475 | 75 | ABBVIE INC. ($339.77) |
| 2022 | $2,066 | 106 | ABBVIE INC. ($385.18) |
| 2021 | $1,231 | 53 | Janssen Biotech, Inc. ($302.73) |
| 2020 | $598.85 | 33 | IRONWOOD PHARMACEUTICALS, INC ($159.92) |
| 2019 | $687.13 | 29 | AbbVie, Inc. ($359.52) |
| 2018 | $121.32 | 6 | AbbVie, Inc. ($69.24) |
| 2017 | $235.94 | 6 | BOSTON SCIENTIFIC CORPORATION ($166.00) |
All Payment Transactions
404 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: LIVER DISEASE | ||||||
| 12/05/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: LIVER DISEASE | ||||||
| 12/02/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: Gastroenterology | ||||||
| 12/02/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.72 | General |
| 11/25/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Education | In-kind items and services | $89.99 | General |
| Category: Immunology | ||||||
| 11/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: Gastroenterology | ||||||
| 11/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.25 | General |
| Category: Immunology | ||||||
| 11/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: Gastroenterology | ||||||
| 11/05/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/31/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $18.74 | General |
| Category: GI | ||||||
| 10/30/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: IMMUNOLOGY | ||||||
| 10/28/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: IMMUNOLOGY | ||||||
| 10/28/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.97 | General |
| 10/23/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.75 | General |
| Category: Immunology | ||||||
| 10/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $112.07 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/22/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: GI | ||||||
| 10/17/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/14/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 1,431 | 9,514 | $569,334 | $182,108 |
| 2022 | 24 | 1,373 | 6,604 | $570,391 | $179,318 |
| 2021 | 22 | 1,374 | 14,357 | $731,228 | $287,049 |
| 2020 | 25 | 1,555 | 14,082 | $697,134 | $282,914 |
All Medicare Procedures & Services
100 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 266 | 378 | $52,920 | $32,258 | 61.0% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2023 | 11 | 1,160 | $58,000 | $28,480 | 49.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 126 | 130 | $105,950 | $23,725 | 22.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 180 | 180 | $33,678 | $18,919 | 56.2% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 53 | 257 | $14,135 | $9,103 | 64.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 147 | 158 | $71,100 | $7,985 | 11.2% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 42 | 46 | $11,316 | $7,321 | 64.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 53 | 153 | $11,475 | $7,164 | 62.4% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 53 | 62 | $67,850 | $6,094 | 9.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 58 | 58 | $8,990 | $5,772 | 64.2% |
| 91120 | Test for tone and sensation of rectum and anus | Office | 2023 | 14 | 14 | $8,260 | $4,963 | 60.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 90 | 92 | $63,020 | $3,971 | 6.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 47 | 65 | $5,525 | $3,884 | 70.3% |
| 46945 | Tying of single internal hemorrhoid group | Facility | 2023 | 14 | 15 | $6,000 | $3,539 | 59.0% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 22 | 35 | $7,350 | $3,163 | 43.0% |
| 91122 | Study of rectum sensitivity and function | Office | 2023 | 14 | 14 | $4,340 | $2,817 | 64.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 15 | 15 | $3,375 | $1,993 | 59.0% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 16 | 16 | $9,280 | $1,593 | 17.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 11 | 11 | $6,380 | $1,427 | 22.4% |
| 74170 | Ct scan of abdomen before and after contrast | Office | 2023 | 11 | 12 | $2,580 | $1,337 | 51.8% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 16 | 16 | $6,160 | $1,216 | 19.7% |
| 76981 | Ultrasound scan of organ tissue for measuring elasticity | Office | 2023 | 13 | 13 | $1,690 | $992.16 | 58.7% |
| 91010 | Study of esophagus to assess movement | Facility | 2023 | 21 | 21 | $1,890 | $980.80 | 51.9% |
| 76705 | Limited ultrasound scan of abdomen | Office | 2023 | 22 | 22 | $1,506 | $926.29 | 61.5% |
| 91035 | Monitoring and recording of esophageal function through a capsule attached to the esophagus wall | Facility | 2023 | 13 | 13 | $1,625 | $802.88 | 49.4% |
About Dr. George Nelson, M.D
Dr. George Nelson, M.D is a Gastroenterology healthcare provider based in Dothan, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/08/2011. The National Provider Identifier (NPI) number assigned to this provider is 1790075950.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. George Nelson, M.D has received a total of $8,417 in payments from pharmaceutical and medical device companies, with $2,002 received in 2024. These payments were reported across 404 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($8,233).
As a Medicare-enrolled provider, Nelson has provided services to 5,733 Medicare beneficiaries, totaling 44,557 services with total Medicare billing of $931,388. Data is available for 4 years (2020–2023), covering 100 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Dothan, AL
- Active Since 04/08/2011
- Last Updated 02/18/2020
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1790075950
Products in Payments
- STELARA (Biological) $933.96
- RINVOQ (Biological) $650.86
- DUPIXENT (Biological) $561.14
- XIFAXAN (Drug) $532.00
- TRULANCE (Drug) $394.65
- Linzess (Drug) $346.15
- ENTYVIO (Biological) $344.50
- ZEPOSIA (Drug) $343.35
- XELJANZ (Drug) $304.73
- SKYRIZI (Biological) $293.45
- EVIS EXERA lll COLONOVIDEOSCOPE (Device) $262.52
- ZENPEP (Drug) $239.01
- IBSRELA (Drug) $202.64
- Mavyret (Drug) $194.24
- DIFICID (Drug) $186.06
- HUMIRA (Biological) $173.84
- REMICADE (Biological) $167.26
- GATTEX (Drug) $164.45
- GIMOTI (Drug) $154.06
- VOQUEZNA (Drug) $140.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Dothan
Mr. Travis Rutland, Md, MD
Gastroenterology — Payments: $265,022
Dr. Paul Lamb, Md, MD
Gastroenterology — Payments: $111,968
Scott Sarrels, M.d, M.D
Gastroenterology — Payments: $15,718
Samuel Tarwater, Md, MD
Gastroenterology — Payments: $15,397
William Mclaughlin, Md, MD
Gastroenterology — Payments: $9,913
Jeffrey Crittenden, Md, MD
Gastroenterology — Payments: $8,300